z-logo
open-access-imgOpen Access
Assessment of Effectiveness and Safety of Osimertinib for Patients With Intracranial Metastatic Disease
Author(s) -
Anders W. Erickson,
Priscilla K. Brastianos,
Sunit Das
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.1617
Subject(s) - osimertinib , medicine , oncology , lung cancer , meta analysis , disease , data extraction , medline , epidermal growth factor receptor , intensive care medicine , cancer , erlotinib , political science , law
This systematic review and meta-analysis assesses the effectiveness and safety of osimertinib in the management of intracranial metastatic disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom